Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection.

Stempel M, Chan B, Juranić Lisnić V, Krmpotić A, Hartung J, Paludan SR, Füllbrunn N, Lemmermann NA, Brinkmann MM.

EMBO J. 2019 Jan 29. pii: e100983. doi: 10.15252/embj.2018100983. [Epub ahead of print]

2.

Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.

Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, Krmpotić A, Jonjić S.

Front Immunol. 2018 May 7;9:991. doi: 10.3389/fimmu.2018.00991. eCollection 2018.

3.

Brain-resident memory CD8+ T cells induced by congenital CMV infection prevent brain pathology and virus reactivation.

Brizić I, Šušak B, Arapović M, Huszthy PC, Hiršl L, Kveštak D, Juranić Lisnić V, Golemac M, Pernjak Pugel E, Tomac J, Oxenius A, Britt WJ, Arapović J, Krmpotić A, Jonjić S.

Eur J Immunol. 2018 Jun;48(6):950-964. doi: 10.1002/eji.201847526. Epub 2018 Mar 23.

PMID:
29500823
4.

Immune responses to congenital cytomegalovirus infection.

Brizić I, Hiršl L, Britt WJ, Krmpotić A, Jonjić S.

Microbes Infect. 2018 Oct - Nov;20(9-10):543-551. doi: 10.1016/j.micinf.2017.12.010. Epub 2017 Dec 26.

PMID:
29287989
5.

NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation.

Miletic A, Lenartic M, Popovic B, Brizic I, Trsan T, Miklic K, Mandelboim O, Krmpotic A, Jonjic S.

Eur J Immunol. 2017 Sep;47(9):1443-1456. doi: 10.1002/eji.201646763. Epub 2017 Jul 21.

6.

Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells.

Tršan T, Vuković K, Filipović P, Brizić AL, Lemmermann NAW, Schober K, Busch DH, Britt WJ, Messerle M, Krmpotić A, Jonjić S.

Eur J Immunol. 2017 Aug;47(8):1354-1367. doi: 10.1002/eji.201746964. Epub 2017 Jul 4.

7.

IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.

Popovic B, Golemac M, Podlech J, Zeleznjak J, Bilic-Zulle L, Lukic ML, Cicin-Sain L, Reddehase MJ, Sparwasser T, Krmpotic A, Jonjic S.

PLoS Pathog. 2017 Apr 27;13(4):e1006345. doi: 10.1371/journal.ppat.1006345. eCollection 2017 Apr.

8.

Mouse cytomegalovirus encoded immunoevasins and evolution of Ly49 receptors - Sidekicks or enemies?

Zeleznjak J, Popovic B, Krmpotic A, Jonjic S, Lisnic VJ.

Immunol Lett. 2017 Sep;189:40-47. doi: 10.1016/j.imlet.2017.04.007. Epub 2017 Apr 13. Review.

PMID:
28414184
9.

A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family.

Aguilar OA, Berry R, Rahim MMA, Reichel JJ, Popović B, Tanaka M, Fu Z, Balaji GR, Lau TNH, Tu MM, Kirkham CL, Mahmoud AB, Mesci A, Krmpotić A, Allan DSJ, Makrigiannis AP, Jonjić S, Rossjohn J, Carlyle JR.

Cell. 2017 Mar 23;169(1):58-71.e14. doi: 10.1016/j.cell.2017.03.002.

10.

Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice.

Milovanovic J, Popovic B, Milovanovic M, Kvestak D, Arsenijevic A, Stojanovic B, Tanaskovic I, Krmpotic A, Arsenijevic N, Jonjic S, Lukic ML.

Front Immunol. 2017 Feb 27;8:192. doi: 10.3389/fimmu.2017.00192. eCollection 2017.

11.

Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.

Tomić A, Varanasi PR, Golemac M, Malić S, Riese P, Borst EM, Mischak-Weissinger E, Guzmán CA, Krmpotić A, Jonjić S, Messerle M.

PLoS Pathog. 2016 Dec 1;12(12):e1006015. doi: 10.1371/journal.ppat.1006015. eCollection 2016 Dec.

12.

Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.

Lenac Rovis T, Kucan Brlic P, Kaynan N, Juranic Lisnic V, Brizic I, Jordan S, Tomic A, Kvestak D, Babic M, Tsukerman P, Colonna M, Koszinowski U, Messerle M, Mandelboim O, Krmpotic A, Jonjic S.

J Exp Med. 2016 Aug 22;213(9):1835-50. doi: 10.1084/jem.20151899. Epub 2016 Aug 8.

13.

Intrinsic Contribution of Perforin to NK-Cell Homeostasis during Mouse Cytomegalovirus Infection.

Arapović M, Brizić I, Popović B, Jurković S, Jordan S, Krmpotić A, Arapović J, Jonjić S.

Front Immunol. 2016 Apr 6;7:133. doi: 10.3389/fimmu.2016.00133. eCollection 2016.

14.

The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.

Arapović J, Arapović M, Golemac M, Traven L, Tomac J, Rumora D, Ražić E, Krmpotić A, Jonjić S.

Med Microbiol Immunol. 2015 Jun;204(3):335-44. doi: 10.1007/s00430-015-0409-y. Epub 2015 Mar 26.

PMID:
25809566
15.

Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread.

Lemmermann NA, Krmpotic A, Podlech J, Brizic I, Prager A, Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler B.

PLoS Pathog. 2015 Feb 6;11(2):e1004640. doi: 10.1371/journal.ppat.1004640. eCollection 2015 Feb.

16.

MCMV avoidance of recognition and control by NK cells.

Brizić I, Lenac Roviš T, Krmpotić A, Jonjić S.

Semin Immunopathol. 2014 Nov;36(6):641-50. doi: 10.1007/s00281-014-0441-9. Epub 2014 Aug 21. Review.

PMID:
25141793
17.

Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.

Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M, Tomic A, Golemac M, Brinkmann MM, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16550-5. doi: 10.1073/pnas.1310215110. Epub 2013 Sep 19.

18.

Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection.

Jordan S, Ruzsics Z, Mitrović M, Baranek T, Arapović J, Krmpotić A, Vivier E, Dalod M, Jonjić S, Dölken L, Koszinowski UH.

Cell Host Microbe. 2013 May 15;13(5):535-545. doi: 10.1016/j.chom.2013.04.007.

19.

The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?

Miletić A, Krmpotić A, Jonjić S.

Eur J Immunol. 2013 Apr;43(4):867-77. doi: 10.1002/eji.201243101. Epub 2013 Mar 18. Review.

20.

Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands.

Handke W, Luig C, Popovic B, Krmpotic A, Jonjic S, Brune W.

J Virol. 2013 Mar;87(6):3592-6. doi: 10.1128/JVI.02657-12. Epub 2013 Jan 9.

21.

Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection.

Mitrović M, Arapović J, Traven L, Krmpotić A, Jonjić S.

Med Microbiol Immunol. 2012 Nov;201(4):487-95. doi: 10.1007/s00430-012-0263-0. Epub 2012 Sep 11. Review.

22.

CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.

Poglitsch M, Weichhart T, Hecking M, Werzowa J, Katholnig K, Antlanger M, Krmpotic A, Jonjic S, Hörl WH, Zlabinger GJ, Puchhammer E, Säemann MD.

Am J Transplant. 2012 Jun;12(6):1458-68. doi: 10.1111/j.1600-6143.2012.04002.x. Epub 2012 Mar 5.

23.

Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo.

Marcinowski L, Tanguy M, Krmpotic A, Rädle B, Lisnić VJ, Tuddenham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkartek C, Babic M, Zimmer R, Trgovcich J, Koszinowski UH, Jonjic S, Pfeffer S, Dölken L.

PLoS Pathog. 2012 Feb;8(2):e1002510. doi: 10.1371/journal.ppat.1002510. Epub 2012 Feb 9.

24.

The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response.

Mitrović M, Arapović J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotić A, Reddehase MJ, Jonjić S.

J Virol. 2012 Feb;86(4):2165-75. doi: 10.1128/JVI.06042-11. Epub 2011 Dec 7.

25.

All is fair in virus-host interactions: NK cells and cytomegalovirus.

Babić M, Krmpotić A, Jonjić S.

Trends Mol Med. 2011 Nov;17(11):677-85. doi: 10.1016/j.molmed.2011.07.003. Epub 2011 Aug 17.

26.

Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains.

Pyzik M, Charbonneau B, Gendron-Pontbriand EM, Babić M, Krmpotić A, Jonjić S, Vidal SM.

J Exp Med. 2011 May 9;208(5):1105-17. doi: 10.1084/jem.20101831. Epub 2011 Apr 25.

27.

Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response.

Slavuljica I, Krmpotić A, Jonjić S.

Front Immunol. 2011 Dec 28;2:85. doi: 10.3389/fimmu.2011.00085. eCollection 2011.

28.

Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Slavuljica I, Busche A, Babić M, Mitrović M, Gašparović I, Cekinović D, Markova Car E, Pernjak Pugel E, Ciković A, Lisnić VJ, Britt WJ, Koszinowski U, Messerle M, Krmpotić A, Jonjić S.

J Clin Invest. 2010 Dec;120(12):4532-45. doi: 10.1172/JCI43961. Epub 2010 Nov 22.

29.

Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo.

Babić M, Pyzik M, Zafirova B, Mitrović M, Butorac V, Lanier LL, Krmpotić A, Vidal SM, Jonjić S.

J Exp Med. 2010 Nov 22;207(12):2663-73. doi: 10.1084/jem.20100921. Epub 2010 Nov 15.

30.

Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands.

Dölken L, Krmpotic A, Kothe S, Tuddenham L, Tanguy M, Marcinowski L, Ruzsics Z, Elefant N, Altuvia Y, Margalit H, Koszinowski UH, Jonjic S, Pfeffer S.

PLoS Pathog. 2010 Oct 14;6(10):e1001150. doi: 10.1371/journal.ppat.1001150.

31.

Modulation of natural killer cell activity by viruses.

Lisnić VJ, Krmpotić A, Jonjić S.

Curr Opin Microbiol. 2010 Aug;13(4):530-9. doi: 10.1016/j.mib.2010.05.011. Epub 2010 Jun 16. Review.

32.

A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.

Mohr CA, Arapovic J, Mühlbach H, Panzer M, Weyn A, Dölken L, Krmpotic A, Voehringer D, Ruzsics Z, Koszinowski U, Sacher T.

J Virol. 2010 Aug;84(15):7730-42. doi: 10.1128/JVI.02696-09. Epub 2010 May 12.

33.

Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.

Zafirova B, Mandarić S, Antulov R, Krmpotić A, Jonsson H, Yokoyama WM, Jonjić S, Polić B.

Immunity. 2009 Aug 21;31(2):270-82. doi: 10.1016/j.immuni.2009.06.017. Epub 2009 Jul 23.

34.

Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.

Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z, Carayannopoulos LN, Koszinowski UH, Krmpotic A, Jonjic S.

J Virol. 2009 Aug;83(16):8198-207. doi: 10.1128/JVI.02549-08. Epub 2009 Jun 3.

35.

Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.

Arapović J, Lenac Rovis T, Reddy AB, Krmpotić A, Jonjić S.

Mol Immunol. 2009 Nov;47(1):114-22. doi: 10.1016/j.molimm.2009.02.010. Epub 2009 Mar 17.

PMID:
19297023
36.

Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.

Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, Babic M, Hill AB, Koszinowski UH, Jonjic S, Lanier LL, Vidal SM.

J Exp Med. 2009 Mar 16;206(3):515-23. doi: 10.1084/jem.20080954. Epub 2009 Mar 2.

37.

Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?

Jonjić S, Polić B, Krmpotić A.

Eur J Immunol. 2008 Nov;38(11):2952-6. doi: 10.1002/eji.200838823. Review.

38.

Dissection of the antiviral NK cell response by MCMV mutants.

Jonjic S, Krmpotic A, Arapovic J, Koszinowski UH.

Methods Mol Biol. 2008;415:127-49. doi: 10.1007/978-1-59745-570-1_8.

PMID:
18370152
39.

Murine cytomegalovirus regulation of NKG2D ligands.

Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S.

Med Microbiol Immunol. 2008 Jun;197(2):159-66. doi: 10.1007/s00430-008-0080-7. Epub 2008 Feb 8. Review.

PMID:
18259774
40.

Immune evasion of natural killer cells by viruses.

Jonjić S, Babić M, Polić B, Krmpotić A.

Curr Opin Immunol. 2008 Feb;20(1):30-8. doi: 10.1016/j.coi.2007.11.002. Review.

41.

The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.

Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A, Messerle M, Ruzsics Z, Koszinowski UH, Hengel H, Jonjic S.

J Exp Med. 2006 Aug 7;203(8):1843-50. Epub 2006 Jul 10.

42.

Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.

Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH.

J Virol. 2005 Mar;79(5):2920-30.

43.

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.

Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S.

J Exp Med. 2005 Jan 17;201(2):211-20. Epub 2005 Jan 10.

44.

Gain of virulence caused by loss of a gene in murine cytomegalovirus.

Bubić I, Wagner M, Krmpotić A, Saulig T, Kim S, Yokoyama WM, Jonjić S, Koszinowski UH.

J Virol. 2004 Jul;78(14):7536-44.

45.

Pathogenesis of murine cytomegalovirus infection.

Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S.

Microbes Infect. 2003 Nov;5(13):1263-77. Review.

PMID:
14623023
46.

MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.

Krmpotić A, Busch DH, Bubić I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjić S.

Nat Immunol. 2002 Jun;3(6):529-35. Epub 2002 May 20.

PMID:
12021778
47.

Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus.

Trgovcich J, Stimac D, Polić B, Krmpotić A, Pernjak-Pugel E, Tomac J, Hasan M, Wraber B, Jonjić S.

Arch Virol. 2000;145(12):2601-18.

PMID:
11205107
48.

The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo.

Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH.

J Exp Med. 1999 Nov 1;190(9):1285-96.

49.

Evaluation of functional nerve recovery shows that allogeneic nerve graft treated with ICAM-1 and LFA-1 mAbs can be good alternative to syngeneic graft.

Stancić MF, Potocnjak M, Mićović V, Krmpotić A, Mackinnon SE.

Acta Neurochir (Wien). 1999;141(8):875-9; discussion 880.

PMID:
10536725
50.

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection.

Polić B, Hengel H, Krmpotić A, Trgovcich J, Pavić I, Luccaronin P, Jonjić S, Koszinowski UH.

J Exp Med. 1998 Sep 21;188(6):1047-54.

Supplemental Content

Loading ...
Support Center